GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $204,000 | – | 4,697 | +234750.0% | 0.01% | – |
| Q1 2022 | $0 | -100.0% | 2 | -99.9% | 0.00% | -100.0% |
| Q4 2021 | $128,000 | -58.0% | 2,902 | -62.1% | 0.00% | -75.0% |
| Q2 2021 | $305,000 | +3.4% | 7,655 | -7.2% | 0.01% | +60.0% |
| Q1 2021 | $295,000 | -62.8% | 8,246 | -61.7% | 0.01% | -79.2% |
| Q4 2020 | $793,000 | +1139.1% | 21,541 | +1176.1% | 0.02% | +2300.0% |
| Q3 2020 | $64,000 | +540.0% | 1,688 | +615.3% | 0.00% | – |
| Q2 2020 | $10,000 | -97.9% | 236 | -98.2% | 0.00% | -100.0% |
| Q1 2020 | $487,000 | +3646.2% | 12,859 | +4698.1% | 0.03% | +2900.0% |
| Q4 2019 | $13,000 | -94.5% | 268 | -95.2% | 0.00% | -93.8% |
| Q3 2019 | $238,000 | +310.3% | 5,579 | +284.2% | 0.02% | +300.0% |
| Q2 2019 | $58,000 | -86.7% | 1,452 | -86.1% | 0.00% | -85.2% |
| Q1 2019 | $437,000 | +10825.0% | 10,443 | +10343.0% | 0.03% | – |
| Q4 2018 | $4,000 | -96.6% | 100 | -96.6% | 0.00% | -100.0% |
| Q3 2018 | $119,000 | -13.8% | 2,982 | -12.9% | 0.01% | +12.5% |
| Q2 2018 | $138,000 | -85.6% | 3,425 | -86.0% | 0.01% | -90.2% |
| Q1 2018 | $956,000 | +13557.1% | 24,464 | +12132.0% | 0.08% | +8100.0% |
| Q4 2017 | $7,000 | +75.0% | 200 | +100.0% | 0.00% | – |
| Q3 2017 | $4,000 | -84.0% | 100 | -82.6% | 0.00% | -100.0% |
| Q2 2017 | $25,000 | -61.5% | 576 | -62.9% | 0.00% | -50.0% |
| Q1 2017 | $65,000 | +6400.0% | 1,551 | +4461.8% | 0.01% | – |
| Q4 2016 | $1,000 | -99.1% | 34 | -98.7% | 0.00% | -100.0% |
| Q3 2016 | $114,000 | +35.7% | 2,640 | +36.9% | 0.01% | +37.5% |
| Q2 2016 | $84,000 | +500.0% | 1,928 | +452.4% | 0.01% | +300.0% |
| Q1 2016 | $14,000 | -51.7% | 349 | -54.1% | 0.00% | -33.3% |
| Q3 2015 | $29,000 | +314.3% | 760 | +341.9% | 0.00% | +200.0% |
| Q2 2015 | $7,000 | – | 172 | +3340.0% | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 5 | -98.9% | 0.00% | -100.0% |
| Q3 2014 | $22,000 | +100.0% | 465 | +132.5% | 0.00% | +100.0% |
| Q2 2014 | $11,000 | -95.4% | 200 | -95.5% | 0.00% | -96.8% |
| Q1 2014 | $238,000 | +266.2% | 4,452 | +266.1% | 0.03% | +181.8% |
| Q4 2013 | $65,000 | -7.1% | 1,216 | -13.6% | 0.01% | +37.5% |
| Q3 2013 | $70,000 | +150.0% | 1,408 | +151.4% | 0.01% | +300.0% |
| Q2 2013 | $28,000 | – | 560 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |